A. Dimou

发表

Novel modalities in the treatment of patients with KRAS-mutated colorectal cancer

K. Syrigos, M. Saif, A. Dimou, 2011, Anti-cancer drugs.

Granulomatosis with polyangiitis in a patient treated with dabrafenib and trametinib for BRAF V600E positive lung adenocarcinoma

R. Doebele, A. Dimou, D. Merrick, 2020, BMC Cancer.

HLA class I binding of mutant EGFR peptides in NSCLC is associated with improved survival.

J. Sidney, A. Sette, R. Doebele, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

MET Gene Copy Number Predicts Worse Overall Survival in Patients with Non-Small Cell Lung Cancer (NSCLC); A Systematic Review and Meta-Analysis

K. Syrigos, Y. Chae, W. Tester, 2014, PloS one.

The effect of calcium channel blockers on the outcome of acute myeloid leukemia

M. Andreeff, H. Kantarjian, Y. Chae, 2014, Leukemia & lymphoma.

Dipstick proteinuria is an independent predictor of high on treatment platelet reactivity in patients on clopidogrel, but not aspirin, admitted for major adverse cardiovascular events

V. Figueredo, T. Monaco, Carlos D Davila, 2015, Platelets.

Changing paradigm in advanced and metastatic non-small cell lung cancer

Kaushal Parikh, D. Uprety, K. Leventakos, 2020, Journal of thoracic disease.

Update on novel therapies for pancreatic neuroendocrine tumors: 2013.

M. Saif, K. Syrigos, A. Dimou, 2013, JOP : Journal of the pancreas.

Neuroendocrine tumors of the pancreas: what's new. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.

K. Syrigos, M. Saif, A. Dimou, 2010, JOP : Journal of the pancreas.

Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancer.

Y. Peterson, R. Gemmill, H. Drabkin, 2020, The Journal of thoracic and cardiovascular surgery.

Association of STK11/LKB1 genomic alterations with lack of benefit from the addition of pembrolizumab to platinum doublet chemotherapy in non-squamous non-small cell lung cancer.

J. Riess, J. Heymach, M. Hellmann, 2019, Journal of Clinical Oncology.

Inhibition of Renin Angiotensin Axis May Be Associated with Reduced Risk of Developing Venous Thromboembolism in Patients with Atherosclerotic Disease

D. Khemasuwan, Y. Chae, W. Tester, 2014, PloS one.

Systemic Therapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancers.

P. Bunn, A. Dimou, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Standardization of epidermal growth factor receptor (EGFR) measurement by quantitative immunofluorescence and impact on antibody-based mutation detection in non-small cell lung cancer.

S. Agarwal, K. Syrigos, D. Rimm, 2011, The American journal of pathology.

Areas of Uncertainty in SARS-CoV-2 Vaccination for Cancer Patients

A. Dimou, 2022, Vaccines.

Is there a role for mitomycin C in metastatic colorectal cancer?

M. Saif, K. Syrigos, A. Dimou, 2010, Expert opinion on investigational drugs.

Novel agents in the management of pancreatic adenocarcinoma: phase I studies. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.

K. Syrigos, M. Saif, A. Dimou, 2011, JOP : Journal of the pancreas.

From the Bench to Bedside: Biological and Methodology Considerations for the Future of Companion Diagnostics in Nonsmall Cell Lung Cancer

K. Harrington, K. Syrigos, A. Dimou, 2011, Pathology research international.

Epigenetics during EMT in lung cancer: EZH2 as a potential therapeutic target

R. Gemmill, H. Drabkin, J. Roche, 2017 .

Predictive value of oncogenic driver subtype, programmed death‐1 ligand (PD‐L1) score, and smoking status on the efficacy of PD‐1/PD‐L1 inhibitors in patients with oncogene‐driven non–small cell lung cancer

D. Aisner, D. Camidge, T. Jiang, 2018, Cancer.

Advances in lung cancer

P. Bunn, A. Dimou, J. Pacheco, 2017, Oncotarget.

Molecular classification of nonsmall cell lung cancer using a 4‐protein quantitative assay

Taxiarchis Botsis, David L Rimm, Dimitrios Dougenis, 2012, Cancer.

Inhibition of the Hedgehog pathway in lung cancer.

H. Gogas, K. Syrigos, A. Bamias, 2019, Lung cancer.

Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 mg in Patients With EGFR-Mutant Non-small Cell Lung Cancer

P. Bunn, R. Doebele, D. Camidge, 2020, Frontiers in Oncology.

Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti–PD-1 Therapies in Metastatic Melanoma

J. Witte, T. Ho, J. Kim, 2018, Clinical Cancer Research.

Disparities in colorectal cancer in African-Americans vs Whites: before and after diagnosis.

M. Saif, K. Syrigos, A. Dimou, 2009, World journal of gastroenterology.

Dramatic Response to Lorlatinib in a Patient With CD74-ROS1-Positive Lung Adenocarcinoma With Acquired F2004V Mutation

S. Ou, R. Doebele, A. Dimou, 2019, JCO precision oncology.

Non-Small Cell Lung Cancer beyond Biomarkers: The Evolving Landscape of Clinical Trial Design

V. Papadimitrakopoulou, A. Dimou, 2014, Journal of personalized medicine.

Novel agents in the treatment of pancreatic adenocarcinoma.

K. Syrigos, M. Saif, A. Dimou, 2013, JOP : Journal of the pancreas.

Imaging in Advanced Non–Small Cell Lung Cancer: A Medical Oncology Perspective

J. Wrangle, A. Dimou, C. Sherman, 2016, Journal of thoracic imaging.

1175P Predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated on the Pacific regimen

A. Mansfield, W. Harmsen, K. Olivier, 2021, Annals of Oncology.

The Role of GSK3β in T Lymphocytes in the Tumor Microenvironment

K. Syrigos, A. Dimou, 2020, Frontiers in Oncology.

Overcoming the stromal barrier: technologies to optimize drug delivery in pancreatic cancer

K. Syrigos, M. Saif, A. Dimou, 2012, Therapeutic advances in medical oncology.

CT Pulmonary Angiography Utilization in the Emergency Department

G. Eiger, A. Dimou, J. Rhee, 2015, American journal of medical quality : the official journal of the American College of Medical Quality.

ROS1 Gene Rearrangements Are Associated With an Elevated Risk of Peridiagnosis Thromboembolic Events

Derek E. Smith, Robert T. Jones, R. Camidge, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Real-world characteristics and outcomes of advanced non-small-cell lung cancer patients with EGFR exon 19 deletions or exon 21 mutations.

Yongmei Chen, M. Leusch, C. Visseren-Grul, 2021, Future oncology.

Measurement of aldehyde dehydrogenase 1 expression defines a group with better prognosis in patients with non-small cell lung cancer.

S. Agarwal, K. Syrigos, D. Rimm, 2012, The American journal of pathology.

Rationale for inhibition of the hedgehog pathway paracrine loop in pancreatic adenocarcinoma.

M. Saif, K. Syrigos, A. Dimou, 2011, JOP : Journal of the pancreas.

Small Cell Transformation in a Patient With RET Fusion-Positive Lung Adenocarcinoma on Pralsetinib.

A. Mansfield, K. Merrell, K. Halling, 2022, JCO precision oncology.

Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.

D. Rimm, M. Prasad, A. Psyrri, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Detection of NRG1 Fusions in Solid Tumors: Rare Gold?

D. Camidge, A. Dimou, 2019, Clinical Cancer Research.